Market Insider

Stocks making the biggest moves premarket: Johnson & Johnson, FedEx, Zions and more

In this article

A FedEx delivery man is seen on Chestnut Street in San Francisco on January 11, 2023 as atmospheric river storms hit California, United States.
Tayfun Coskun | Anadolu Agency | Getty Images

Check out the companies making headlines before the bell Wednesday.

Johnson & Johnson — The pharmaceutical giant climbed 2.6% after announcing Tuesday it will pay $8.9 billion over the next 25 years to settle claims that the talc in its baby powder and other products caused cancer. J&J also refiled for bankruptcy protection for its LTL Management subsidiary and said it continues to believe the claims lack merit.

Zions Bancorporation — Shares of Zions Bancorporation rose 3.2% after Baird upgraded the regional bank stock to an outperform rating. The firm said shares are trading at attractive levels not seen since the global financial crisis.

Clean Energy Fuels — The stock was 3.6% higher after Raymond James upgraded Clean Energy Fuels to outperform and assigned it a $6 price target, suggesting shares stand to gain about 42.8% from Tuesday’s close.

Albemarle — Albemarle shed 3.3% after Bank of America downgraded the chemicals manufacturing stock to underperform from neutral. The bank significantly cut its earnings forecast for Albemarle and lowered its price target to $195. The new target implies the stock could fall about 7% from Tuesday’s close.

Lamb Weston — Shares of the potato processing giant were up about 1% ahead of the company’s scheduled earnings release on Thursday. Bank of America included Lamb Weston in its recent list of short-term stock picks for the second quarter, saying it is optimistic the company will beat consensus earnings estimates.

FedEx — Shares of the shipping company gained 3.1% in premarket trading after FedEx announced a dividend hike and a corporate reorganization. FedEx said it will raise its dividend by 10%, consolidate its different business divisions and change its executive compensation packages.

Exelixis — Shares of the biotech company added 1% after The Wall Street Journal reported that hedge fund Farallon Capital Management is planning to wage a proxy battle at Exelixis.

— CNBC’s Jesse Pound, Samantha Subin and Michelle Fox Theobald contributed reporting.

Articles You May Like

Warren Buffett says Berkshire may only do slightly better than the average company due to its sheer size
3 Market Disruptors Ready to Triple Your Investment
What Would Warren Buffett Do? 7 Stocks Berkshire Bought & Sold in Q4
Palantir Outlook: 3 Reasons Why Investors Should Be Cautious on PLTR Stock
Bringing Up the Rear: 3 Key Stocks to Watch Before Q4 Earnings Come to an End